Clinical Trial Update: Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV [Phase 2]

View source ↗

Summary

Phase 2 trial comparing rifampin-based versus rifabutin-based tuberculosis treatment in people with HIV; study terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Rifabutin-based tuberculosis treatment (rifabutin)
• Rifampin-based tuberculosis treatment (rifampin)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV Infection, Tuberculosis | Phase 2 | Status: TERMINATED | Results posted: 2018-02-13